NCT01684891View on ClinicalTrials.gov

A 28-Day Pharmacokinetics Study of RG1662 in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

October 31, 2012

Study Completion Date

October 31, 2012

Conditions
Healthy Volunteer
Interventions
DRUG

RG1662

multiple doses of RG1662

Trial Locations (1)

9471 GP

Zuidlaren

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01684891 - A 28-Day Pharmacokinetics Study of RG1662 in Healthy Male Volunteers | Biotech Hunter | Biotech Hunter